About Obesity and Diabetes 2019

3rd International Conference on Obesity, Nutrition & Endocrinology

The Obesity and Diabetes 2019 aims to focus on the clinical aspects of diabetes and to update the attendees with the current knowledge and understanding of the treatment of diabetes and its complications. We have come forward with this "Obesity and Diabetes 2019" is going to be held on March 11-13, 2018 at Milan, Italy by Cenetri Publishing Group and this will encompass a variety of up-to-date knowledge on diabetes and metabolism.

The scientific sessions offer researchers and health-care professionals a unique opportunity to share ideas and learn about significant advances in diabetes research, treatment and care. Over the course of three days, participants will receive exclusive access to more than 30 dynamic and innovative sessions, take part in engaging exchanges with industry-leading experts and expand professional networks. With the best-in-class Speakers from the leading global Diabetes Institutions - this conference would help bring the latest and the best practices in Diabetes care to Clinicians treating people with Diabetes.

Scope and Importance

Diabetes is increasing in epidemic proportions worldwide. In India alone, more than 68 million people have Diabetes. The need of the hour is to empower Health Care providers with Basic and Advanced Diabetes Care expertise for better management of Diabetes and its associated complications. Diabetes prevalence has been rising more rapidly in middle- and low-income countries and is a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation.

Number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. Among adults, prevalence of diabetes, over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. In 2015, an estimated 1.6 million deaths were directly caused by diabetes. Another 2.2 million deaths were attributable to high blood glucose in 2012. Almost half of all deaths attributable to high blood glucose occur before the age of 70 years. WHO projects that diabetes will be the seventh leading cause of death in 2030.

Approximately 415 million adults have diabetes; by 2040 this will rise to 642 million. Diabetes caused 5 million deaths in 2015; every six seconds a person dies from diabetes and More than 20.9 million live births were affected by diabetes during pregnancy in 2015 – 1 in 7 births. Diabetes is currently the fifth most common reason for death in the world. Around 1 in 8 people between 20 and 79 years old have their death attributed to diabetes and it is expected to rise. It is currently estimated that around 10% of the NHS yearly budget is contributed to the treatment of diabetes. This equates to nine billion a year or rather, £173 million a week.

Diabetic Devices Market

The global diabetes patient pool is expected to reach 380 million by 2025 because of increasing aging population, sedentary lifestyle, and unhealthy dietary patterns. The insulin delivery devices market is forecasted to grow at a CAGR of 5.59 % to reach revenues of USD 14.22 billion in 2019. The global market for diabetes care devices is forecasted to reach USD 30.25 billion by 2021 at a CAGR of 5.93%. Glucose monitoring devices will be the largest category in the market, with a value of USD 15.96 billion by 2021 with a CAGR of 6.02%. The glucose monitoring devices market will show moderate growth by 2019. CGM devices are increasingly being widely used and saw growth of just under 20% in 2012.

In 2015, the test-strips sub-segment captured the largest market share in the blood glucose monitoring and diagnostic devices segment. The insulin pens accounted for the largest share of the insulin delivery devices segment. The global diabetes devices market is expected to reach USD 35.4 billion in 2024. North America captured the largest market share of around 32% in the year 2015. The domination of the market is expected to continue with a CAGR of 5.9%. Insulin delivery devices landscape in the US will allow for strong growth by 2017 and the insulin syringe patient share will decrease, while the insulin pen and insulin pump patient share will increase over the next five years.

Scientific Sessions

  • Obesity and Metabolism
  • Paediatric Obesity
  • Eating and Obesity - Cultural Perspectives
  • Progressing Policies for Obesity
  • Surgical and Non-surgical Treatments
  • Obesity and Cardiac issues
  • Obesity - Health Risks
  • Genetic Obesity
  • Clinical Research and Interventions in Obesity
  • Obesity and Cardiac issues
  • Endocrinal and Hormonal Obesity
  • Diabetes Market and Business Analysis
  • Cadio-Diabetes
  • Endocrinopathy in Cancer
  • Ties between Obesity and Diabetes
  • Consequences of Obesity on Cancer
  • New Directions in Obesity Treatment
  • Insights on Nutritional Findings and Eating Disorders
  • Weight Management
  • Preface to Obesity and Overweight
  • Clinical Management
SUBMIT YOUR ABSTRACT

Why to Attend ?

The scientific sessions offer researchers and health-care professionals a unique opportunity to share ideas and learn about significant advances in diabetes research, treatment and care. Over the course of three days, participants will receive exclusive access to more than 30 dynamic and innovative sessions, take part in engaging exchanges with industry-leading experts and expand professional networks. With the best-in-class Speakers from the leading global Diabetes Institutions - this conference would help bring the latest and the best practices in diabetes and obesity care to Clinicians treating people with Diabetes and Obesity.

Target Audience

  • Diabetologists
  • Endocrinologists
  • Doctors
  • Dieticians
  • Obesity Specialists
  • Health Professionals
  • Academic Professionals
  • Business Entrepreneurs
  • Medical Colleges and Hospitals
  • Medical and Pharma Companies
  • Diabetes and Endocrinology Societies and Associations
  • Obesity Societies and Associations
  • Students
  • Researchers